✦ LIBER ✦

Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium

✍ Scribed by Lieven Annemans; Daniëlle Strens; Erica Lox; Christine Petit; Hughes Malonne

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 176 KB
Volume: 16
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-007-0349-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetics of aprepitan

Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting

✍ Susumu Nakade; Tomoya Ohno; Junsaku Kitagawa; Yoshitaka Hashimoto; Masahiro Kata 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 509 KB

The cost of chemotherapy-induced nausea

The cost of chemotherapy-induced nausea and vomiting in Italy

✍ Enzo Ballatori; Fausto Roila; Benedetta Ruggeri; Stella Porrozzi; Mauro Iannopol 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 112 KB

Aprepitant, dexamethasone, and palonoset

Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting

✍ Paul J. Hesketh; Pedro Sanz-Altamira 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Ondansetron versus granisetron in the pr

Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting

✍ Paola Fedele; Michele Spina; Mariagrazia Valentini; Doriana Collini; Cadorin Luc 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Establishing the dose of the oral NK1 an

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting

✍ Sant P. Chawla; Steven M. Grunberg; Richard J. Gralla; Paul J. Hesketh; Cindy Ri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

## Abstract ## BACKGROUND The neurokinin‐1 antagonist aprepitant (EMEND™; Merck Research Laboratories, West Point, PA) has been shown to reduce chemotherapy‐induced nausea and vomiting when it is given with a 5‐hydroxytryptamine‐3 receptor antagonist and dexamethasone. The current study sought to

Tropisetron (Navoban) in the prevention

Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting — the Nordic experience

✍ Bengt Sorbe; Håkan Andersson; Margareta Schmidt; Martin Söderberg; Thomas Högber 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 911 KB